USA UK
  • SIGNUP TO OUR NEWSLETTER
The Anal Cancer Foundation
  • Anal Cancer
    • Living With Anal Cancer: Effects & Recovery
      • Support for Newly Diagnosed Anal Cancer Patients
      • Anal Cancer Diagnosis
      • Questions to Ask your Doctor
      • Talking to Friends & Family About Diagnosis
    • Treatment
      • Anal Cancer Treatment Options
        • Surgery
        • Radiation Therapy
        • Chemotherapy
        • Novel Treatment
        • Nigro Protocol
      • Side Effects of Anal Cancer Treatment
      • Treatment Options for Recurrent & Advanced Anal Cancer
      • Clinical Trials for Anal Cancer Treatment
    • What is Anal Cancer
      • Anal Cancer Stages and Grading
      • Anal Precancer + screening
      • A Guide to High Resolution Anoscopy (HRA)
      • Anal Cancer Risk Factors & Prevention
      • What is HPV
      • HPV Vaccine: Types, Safety & Who It Is For
      • HPV and Anal Cancer
      • Anal Cancer vs Hemorrhoids
      • Anal Cancer vs Rectal Cancer
  • Thriver Stories
  • Support
    • Support for Anal Cancer Patients
      • Patients: Connect with a Peer
      • Thriver Stories: Anal Cancer Patient Stories
      • Support Resources
      • Medical Resources
      • Financial Resources
    • Support for Anal Cancer Caregivers
      • Tips for being a Caregiver to a Cancer Patient
      • Caregivers: Connect with a Peer
  • Take Action
    • Fundraise for Us!
      • Facebook Fundraisers
      • Become an athlete for a cure
      • Host a Party
      • Patient Ambassadors
      • Volunteer / Intern
    • Donate to Find a Cure
      • Donate
      • Other Ways to Give
      • Employee Matching
    • Community
      • Anal Cancer Patient Summit
      • Anal Cancer Awareness Day
  • News & Events
    • News
    • Events
  • Role & Impact
    • About Us
      • Mission
      • Our Story
      • Who We Are
    • Our Impact
      • Accomplishments
      • Research Roadmap
      • In The Press
    • Join Us
    • Contact Us
    • Press Kit
Donate
Home / Anal Cancer: Signs, Symptoms, Causes & Treatment / Anal Cancer Stages and Grading

Anal Cancer Stages and Grading

Anal Cancer Stages and Grading

After an anal cancer diagnosis, “staging” occurs which is where doctors try to determine how large the cancer is and if it has spread. This helps determine the best course of treatment. To explore the basics of what anal cancer is, including symptoms and risk factors, visit our anal cancer overview page.

By understanding the different stages of anal cancer, patients and their loved ones can better comprehend the extent of the disease and the potential treatment options available to them.

TNM staging

The most common staging system is the American Joint Committee on Cancer (AJCC) TNM system. This is based on 3 key pieces of information:

  • Tumor: What is the size of the main tumor (T)? Has it grown into (or metastasized) nearby organs?
  • Nodes: Has the cancer spread to nearby lymph nodes (N)
  • Metastasis: Has the cancer metastasized (M, meaning spread) to distant lymph nodes or distant organs such as the liver or lungs?

Combining TNM Categories to Determine Stage

Numbers/letters after T, N, and M provide more details about each of the three pieces of information. Higher numbers mean the cancer is more advanced.

Once you have your T, N, and M categories the information is combined to assign an overall stage.

The American Cancer Society has a helpful graphic to help explain the various combinations of staging.

Anal intraepithelial neoplasia (AIN)

All growths and abnormal changes in the epithelial (skin) cells in and around the anal area are known as AIN (anal intraepithelial neoplasia). These changes are associated with infection with HPV (the human papillomavirus), which is a risk factor for anal cancer. AIN is not cancer however, it is also known as precancer.

Stage 1 anal cancer

This indicates that the tumor is 2 cm or smaller, and it has not spread to the lymph nodes or other parts of the body. It is staged as T1, N0, M0.

Stage 2 anal cancer

Stage 2 means that the tumor is larger than 2 cm, but has not spread to nearby organs, lymph nodes, or to other parts of the body. It is staged as T2 or T3, N0, M0.

Stage 3 anal cancer

  • Stage 3A: The tumor is 5 cm or smaller and has not invaded nearby organs. However, there is spread to nearby lymph nodes. This is staged T1 or T2, N1, M0.
  • Stage 3B: The tumor has invaded nearby organs, but there is still no spread to lymph nodes or distant orange. It is staged T4, N0, M0.
  • Stage 3C: The tumor is 5 cm larger and/or has invaded nearby organs, and it has spread to nearby lymph nodes. It has not spread to distant organs. This is staged T3 or T4, N1, M0.

Stage 4 anal cancer

This indicates that the tumor has spread to the lymph nodes and to distant organs. It can be any size (so any T, any M, and M1).

Anal cancer grading

  • Your doctor may also describe anal cancer by its grade (G). This describes how much cancer cells look like healthy cells under a microscope. The grade can help predict how quickly the cancer may spread. Generally, a lower grade means a better prognosis.
  • To determine this, cancerous cells are compared with healthy tissue, which usually contains many different types of cells, all grouped together.
  • If the cancer looks similar to healthy tissue, it is called “differentiated” or a “low-grade tumor.”
  • If the cancerous tissue does not look like healthy cells, it is termed “poorly differentiated” or a “high-grade tumor.”

Prognosis

Information from the Surveillance, Epidemiology, and End Results (SEER) database, maintained by the National Cancer Institute (NCI) is a trusted source of survival statistics. It tracks 5-year relative survival rates for anal cancer in the United States, based on how far the cancer has spread. The SEER database groups cancers into localized, regional, and distant stages (not by stage):

  • Localized: There is no sign that the cancer has spread outside of the anal area.
  • Regional: The cancer has spread outside the anal area to nearby structures or lymph nodes.
  • Distant: The cancer has spread to distant parts of the body, such as the liver or lungs.

Anal Cancer treatment by stages

The treatment regimens for anal cancer are primarily for squamous cell carcinoma, which accounts for more than 90% of all anal cancers.

For stages I – III, the standard protocol is radiation and chemotherapy, used in conjunction with one another (often called 'chemoradiation'). This combination is known as the Nigro Protocol. The Nigro Protocol typically includes several weeks of radiation with two different types of chemotherapy given at the beginning and end of treatment.

Learn more about the side effects of chemotherapy and radiation.

Surgery can be used for early-stage anal cancer when the tumor is extremely small and localized.

Stage IV cancers are usually addressed with chemotherapy alone first. Learn more about treatment for recurrent and advanced anal cancers.

Other resources

  • Learn more about Immunotherapy and Clinical Trials for anal cancer.
  • Check out the sessions on treatment for metastatic anal cancer treatment from our 2023 patient summit.

After an anal cancer diagnosis, “staging” takes place. This is where doctors try to determine how large the cancer is and whether it has spread. This helps determine the most appropriate course of treatment. To explore the basics of what anal cancer is, including symptoms and risk factors, visit our anal cancer overview page.

By understanding the different stages of anal cancer, patients and their loved ones can better comprehend the extent of the disease and the potential treatment options available to them.

TNM staging

The most common staging system is the American Joint Committee on Cancer (AJCC) TNM system. This is based on 3 key pieces of information:

  • Tumour: What is the size of the main tumour (T)? Has it grown into (or metastasized) nearby organs?
  • Nodes: Has the cancer spread to nearby lymph nodes (N)
  • Metastasis: Has the cancer metastasized (M, meaning spread) to distant lymph nodes or distant organs such as the liver or lungs?

Combining TNM Categories to Determine Stage

Numbers or letters after T, N, and M provide more details about each of the three pieces of information. Higher numbers mean the cancer is more advanced.

Once you have your T, N, and M categories the information is combined to assign an overall stage.

The American Cancer Society has a helpful graphic explaining the various combinations of staging.

Anal intraepithelial neoplasia (AIN)

All growths and abnormal changes in the epithelial (skin) cells in and around the anal area are known as AIN (anal intraepithelial neoplasia). These changes are associated with infection with HPV, the human papillomavirus, which is a risk factor for anal cancer.

AIN is not cancer. However, it is sometimes described as a precancerous condition.

Stage 1 anal cancer

Stage 1 anal cancer means the tumour is 2 cm or smaller, and it has not spread to the lymph nodes or other parts of the body. It is staged as T1, N0, M0.

Stage 2 anal cancer

Stage 2 anal cancer means that the tumour is larger than 2 cm, but has not spread to nearby organs, lymph nodes, or to other parts of the body. It is staged as T2 or T3, N0, M0.

Stage 3 anal cancer

  • Stage 3A: The tumour is 5 cm or smaller and has not invaded nearby organs. However, it has spread to nearby lymph nodes. This is staged as T1 or T2, N1, M0.
  • Stage 3B: The tumour has invaded nearby organs, but there is still no spread to lymph nodes or distant organs. It is staged as T4, N0, M0.
  • Stage 3C: The tumour is 5 cm larger and/or has invaded nearby organs, and it has spread to nearby lymph nodes. It has not spread to distant organs. This is staged as T3 or T4, N1, M0.

Stage 4 anal cancer

Stage 4 anal cancer means that the cancer has spread to distant parts of the body, such as distant lymph nodes, the liver, or the lungs. The tumour can be any size. This is staged as any T, any N, M1.

Anal cancer grading

  • Your doctor may also describe anal cancer by its grade (G). This describes how much cancer cells look like healthy cells under a microscope. The grade can help predict how quickly the cancer may spread. Generally, a lower grade means a better prognosis.
  • To determine this, cancerous cells are compared with healthy tissue, which usually contains many different types of cells grouped together.
  • If the cancer looks similar to healthy tissue, it is called “differentiated” or a “low-grade tumour.”
  • If the cancerous tissue does not look like healthy cells, it is termed “poorly differentiated” or a “high-grade tumour.”

Prognosis

The prognosis for anal cancer depends on several factors, including the stage of the cancer, tumour size, whether it has spread to lymph nodes or other parts of the body, overall health and response to treatment. Survival statistics can give a general guide, but they cannot predict exactly what will happen for any one person.

Anal Cancer treatment by stages

The treatment regimens for anal cancer are primarily for squamous cell carcinoma, which accounts for more than 90% of all anal cancers.

For stages I to III, the standard treatment is radiation therapy and chemotherapy, used together. This is often called chemoradiation. This combination is known as the Nigro Protocol. The Nigro Protocol typically includes several weeks of radiotherapy, with two different types of chemotherapy given at the beginning and end of treatment.

Learn more about the side effects of chemotherapy and radiation.

Surgery can be used for early-stage anal cancer when the tumour is extremely small and localised.

Stage IV cancers are usually addressed with chemotherapy alone first. Learn more about treatment for recurrent and advanced anal cancers.

Other resources

  • Learn more about Immunotherapy and Clinical Trials for anal cancer.
  • Watch the sessions on treatment for metastatic anal cancer treatment from our 2023 patient summit.

Share this: on Twitter on Facebook

Latest News

  • IANS Anal Cancer Prevention Screening Toolkit
  • Let’s Talk Anal Cancer: Elevating Community Voices
  • NavDx Test gains expanded Medicare coverage: What anal cancer patients should know
  • DPD Deficiency Testing before 5-FU Treatment for Anal Cancer: What you should know
  • FDA APPROVE RETIFANLIMAB-DWLR (ZYNYZ®) FOR ADVANCED ANAL CANCER: WHAT YOU SHOULD KNOW
  • Heart beat iconSupport for Newly Diagnosed Anal Cancer Patients
  • About iconManaging your Symptoms
  • People iconJoin the Community

Newsletter Sign-up

Subscribe to our newsletter to receive updates on our crucial work to help eliminate anal cancer.

Charity Info

The Anal Cancer Foundation is dedicated to empowering anal cancer patients and accelerating prevention and research methods that eliminate anal cancer and the virus that causes the majority of cases, HPV.

USA: The HPV and Anal Cancer Foundation is a 501(c)(3) non-profit organization.
Tax ID/EIN: 27-3217520

UK: The HPV and Anal Cancer Foundation Limited is registered with the charity commission for England and Wales (1147457)

 

Contact Us

ACF USA
PO Box 232
New York, NY 10272
+1.646.593.7739
ACF UK
128 City Road
London
EC1V 2NX
0203 488 6567

Email us at:

info@analcancerfoundation.org

Twitter

[db_twitter_feed count=”3″]

Partners NOMAN Campaign logo

© 2026 The Anal Cancer Foundation

  • Terms and Conditions
  • Privacy Policy
×
You are currently viewing United States-based content. Do you want to view the United Kingdom version?
Yes, Take me to the united kingdom website